Effects of dexmedetomidine for sedation of patients undergoing breast local biopsy requiring MAC

XIAO Liang-can,JIANG Nan,LI Qiang,FANG Jie-yu,DENG Sheng-hua,HUANG Wen-qi

DOI: https://doi.org/10.3969/j.issn.1674-0793.2012.04.009

2012-01-01

Abstract:Objective To evaluate the safety and efficacy of dexmedetomidine for sedation of patients undergoing breast local biopsy requiring monitored anesthesia care(MAC).Methods Ninty patients were randomly divided into group D1(DEX 0.5μg/kg loading dose,followed by a maintenance infusion of 0.125 ml·kg~(-1)·-h~(-1) saline),group D2(DEX 0.5μg/kg initial loading dose,followed by a maintenance infusion of 0.5μg·kg~(-1)·h~(-1)),or group P(quivalent volume of saline placebo) titrated to a targeted level of sedation and pain.Study drug was started 30 min before placement of local anesthetic block.Midazolam was given for OAA/S>4 and fentanyl for VAS>4.The midazolam and fentanyl requirements,respiratory depression,and patient's satisfaction of surgical procedure were recorded. Restlts Significantly fewer patients in group D1 and group D2 required supplemental midazolam compared with group P(P<0.05) and at lower doses to achieve an OAA/S≤4 before and during surgery compared with group P(P<0.05).Group D2 required the lowest doses to achieve an OAA/S≤4 compared with group Dl(P<0.05).Both group D1 and group D2 required significantly less fentanyl and patient satisfaction was significantly higher with both group Dl and D2 compared with group P(respectively,P<0.05).The incidence of clinically significant tachycardia,hypertension and respiratory depression were lower in group D1 and D2 compared with group P(respectively,P<0.05).Conclusions DEX is an effective baseline eadative for patients undergoing MAC for breast local biopsy providing better patient satisfaction,less midazolam and fentanyl requirements,and less circulation,respiratory complica-tion. Loading dose and followed by a maintenance infusion of DEX require the lowest doses than placebo rescured with midazolam.